Published in PLoS One on May 12, 2014
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Leukemia (2014) 0.93
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy. Br J Cancer (2015) 0.82
Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget (2016) 0.81
DAMPs, ageing, and cancer: The 'DAMP Hypothesis'. Ageing Res Rev (2014) 0.81
Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors. Cancer Sci (2015) 0.78
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease. Expert Opin Ther Targets (2015) 0.78
Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines. Proteome Sci (2015) 0.78
Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia. BMC Cancer (2017) 0.75
Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy. Oncotarget (2016) 0.75
High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway. Onco Targets Ther (2016) 0.75
Autophagy and multidrug resistance in cancer. Chin J Cancer (2017) 0.75
HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation. Oncotarget (2017) 0.75
Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance. Mol Med Rep (2016) 0.75
Overactivated autophagy contributes to steroid-induced avascular necrosis of the femoral head. Exp Ther Med (2017) 0.75
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem (2007) 21.73
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Methods in mammalian autophagy research. Cell (2010) 20.08
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 15.71
Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet (2004) 14.31
Autophagy and the integrated stress response. Mol Cell (2010) 11.21
A unified nomenclature for yeast autophagy-related genes. Dev Cell (2003) 9.18
Eaten alive: a history of macroautophagy. Nat Cell Biol (2010) 8.83
Acute lymphoblastic leukaemia. Lancet (2008) 8.54
Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep (2001) 7.13
The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ (2011) 5.95
Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ (2009) 5.28
The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci (1996) 4.63
S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol (2006) 4.20
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83
S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech (2003) 1.99
Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology (2005) 1.82
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol (2008) 1.82
Selective autophagy in cancer development and therapy. Cancer Res (2010) 1.79
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect (2004) 1.63
Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene (2011) 1.43
Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst (2006) 1.40
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. Leukemia (2011) 1.26
Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS One (2011) 1.22
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta (2007) 1.19
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia (2012) 1.17
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood (2011) 1.16
DAMP-mediated autophagy contributes to drug resistance. Autophagy (2011) 1.10
Childhood acute myeloid leukaemia. Br J Haematol (2012) 1.04
Proteomic analysis of human acute leukemia cells: insight into their classification. Clin Cancer Res (2004) 0.90
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia (2012) 0.90
Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy (2012) 0.89
Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. Atherosclerosis (2011) 0.86
The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice. Mol Immunol (2012) 0.86
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients. Leukemia (2010) 0.86
S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy. Int J Mol Med (2011) 0.85
Changing picture of cellular drug resistance in human leukemia. Crit Rev Oncol Hematol (2004) 0.79
WAVE1 regulates P-glycoprotein expression via Ezrin in leukemia cells. Leuk Lymphoma (2011) 0.77